Previous Article | Next Article ![]()
Applied and Environmental Microbiology, December 2003, p. 7401-7408, Vol. 69, No. 12
0099-2240/03/$08.00+0 DOI: 10.1128/AEM.69.12.7401-7408.2003
Copyright © 2003, American
Society for
Microbiology. All Rights Reserved.
G. Sabat,2,
and W. J. Hickey1,2*
Center for Molecular and Environmental Toxicology,1 Department of Soil Science, University of WisconsinMadison, Madison, Wisconsin2
Received 17 March 2003/ Accepted 8 September 2003
|
|
|---|
|
|
|---|
Uptake of aromatic acids by bacteria can be transporter mediated or driven by diffusion across intracellular/extracellular gradients of pH and substrate concentration (20). Establishment and maintenance of concentration gradients requires the intracellular substrate concentration to be kept low relative to that of the external environment, which may be achieved by rapid transformation of the imported compound to metabolic intermediates (11, 26, 37). Thus, in this case uptake is effectively driven by the activity of catabolic enzymes, and this "metabolic drag" (37) mechanism has been proposed for the uptake of benzoate (11) and 4-hydroxybenzoate (4-HBa) (26) in Rhodopseudomonas palustris and uptake of 4-HBa by Rhizobium leguminosarum (37).
Transporter-mediated uptake has been demonstrated for several aromatic acids with a variety of bacteria. These compounds and organisms include benzoate (Pseudomonas putida [35], Acinetobacter sp. ADP1 [9]), 4-HBa (Klebsiella pneumoniae [5], Acinetobacter sp. [2]), Klebsiella planticola [3], P. putida [12]), protocatechuate (P. putida [28]), mandelate (P. putida [17]), phenylacetate (P. putida [33]), 4-hydroxyphenylacetate (Escherichia coli [31], K. pneumoniae [4]), and phthalate and 4-methylphthalate (Burkholderia fungorum [8, 32]). Chlorinated aromatic compounds for which transporters have been demonstrated are 4-chlorobenzoate (coryneform bacterium strain NTB-1 [10]), 2,4-dichlorophenoxyacetate (Ralstonia eutropha [24], Sphingomonas herbicidovorans [38]), and dichlorprop (S. herbicidovorans [38]). For most of these, the carrier that mediated uptake was demonstrated or implicated as being a secondary transporter, which utilized energy stored in electrochemical gradients of the cytoplasmic membrane to drive substrate movement. For only two of the compounds and organisms described above was uptake proposed to be mediated by an ABC-type primary transporter (energized by ATP hydrolysis): 4-hydroxyphenylacetate in K. pneumoniae strain M5a1 (4) and 4-HBa in Acinetobacter sp. strain BEM2 (2).
Pseudomonas huttiensis strain D1 acquired the ability to utilize a variety of ortho-halobenzoates by horizontal transfer of genes from Pseudomonas aeruginosa strain JB2 (29). Biodegradation genes acquired by strain D1 from strain JB2 that have been characterized to date include those encoding a salicylate 5-hydroxlase (hybABCD [15]) and a 2-halobenzoate 1,2-dioxygenase (ohbAB [14]). Also identified previously was a cluster of genes (hybEFG) immediately downstream of hybABCD whose products had significant identities to components of an ABC-type transporter (15). The potential activity of this putative transporter in mediating uptake of salicylate or 2-chlorobenzoate (2-CBa) was not determined.
In the present study, we focused on P. huttiensis strain D1 and investigated the uptake mechanisms for 2-CBa and 2-hydroxybenzoate (2-HBa). Our objectives were to determine if uptake was an active transporter-mediated process, define the kinetic parameters of transport, elucidate the substrate range of the transport system, link transport energetics to either ATP hydrolysis or electrochemical gradients, and determine if the putative ABC transporter encoded by hybEFG was involved with 2-CBa or 2-HBa uptake.
|
|
|---|
Uptake
assays.
Radiolabeled
compounds used in these assays were
2-[U-ring-14C]CBa (purity, 96%;
specific activity, 29 mCi mmol-1) obtained from
Sigma Chemical Co. (St. Louis, Mo.) and
2-[U-ring-14C]Ba (purity, 99%;
specific activity, 15 mCi mmol-1) from American
Radiolabeled Chemicals, Inc. (St. Louis, Mo.). For 2-CBa uptake assays,
a hot-cold stock solution (specific activity, 2.9 mCi
mmol-1) was prepared in sterile 50 mM
NaKPO4 buffer with 100 µM
2-[14C]CBa and 900 µM unlabeled 2-CBa
(purity, 98%; Aldrich, Milwaukee, Wis.). A hot-cold stock
solution of 2-HBa (specific activity, 3.0 mCi
mmol-1) contained 200 µM
2-[14C]HBa with 800 µM unlabeled 2-HBa
(purity, 99%; Sigma).
Cells were harvested by centrifugation (6,000 x g, 10 min), washed once with assay buffer (50 mM NaKPO4 [pH 7.0]), and resuspended in this buffer to an optical density corresponding to 0.05 ± 0.01 mg of total cellular protein ml-1. For the assays, cell suspension (1 ml) was incubated at 30°C for 10 min on a shaker rotating at 120 rpm, and reactions were initiated by addition of the hot-cold stock solutions. For kinetic determinations, the concentration of 2-[14C]CBa was varied from 2.5 to 60 µM, all other reactions contained 10 µM (29 nCi) of 2-[14C]CBa or 2-[14C]HBa (30 nCi). Aliquots (200 µl) were removed from the reaction mixture at 30-s intervals for 2.5 min. Cells were filtered onto nitrocellulose membranes (0.45-µm-pore-size diameter; Whatman International Ltd., Maidstone, England) on a vacuum manifold and rinsed with 4 ml of assay buffer. Reactions were quenched by placing the filters in ScintiSafe scintillation cocktail preheated to 70°C. Membranes were removed from the manifold at 30-s intervals, such that each remained on the manifold for 2.5 min after cells were filtered onto it. The delay resulted in 24% ± 6% loss of 14C activity on the membranes, presumably reflecting mineralization of 2-[14C]CBa and 2-[14C]HBa.
Radioactivity on the filters was counted on a RackBeta liquid scintillation counter (LKB Wallac, Turku, Finland). Uptake rates for each reaction were calculated from the slope of the linear regression of total 14C activity in the cells versus time. For all assays, the linear regression extrapolated to time zero did not pass through the origin. Due to limitations of the sampling methods, however, measurements before 0.5 min were not possible. Thus, unless otherwise indicated, the slope of the line between 0.5 and 2.0 or 2.5 min was used to calculate uptake rates. All transport rates and ATP levels were normalized to total protein present in the reaction, which was determined by a modified Bradford method (7). Statistical differences between uptake rates were assessed by Student's t test.
Values for Vmax and Km were estimated by nonlinear regression fitting to the Michaelis-Menten equation. This was done using the Solver function of Microsoft Excel to minimize the sum of the squared error between measured and calculated uptake rates for each 2-CBa concentration. Goodness-of-fit was evaluated by the coefficient of determination.
Extraction
and analysis of intracellular substrate pools.
Uptake assay mixtures were prepared
as described above, but the entire 1-ml volume was sampled 1 min after
the addition of 2-[14C]CBa or
2-[14C]HBa. The assay was repeated eight times,
and the filters were pooled. Analysis was based on a procedure
described by Miguez et al.
(27). The filters were
immediately placed in a vial containing 9 ml of hot water (preheated to
90°C). Filtrate from each of the reactions was collected in a
scintillation cocktail in order to determine the extracellular
concentration of substrate. Filters were incubated at 90°C for
15 min with occasional vortex mixing, and then the water was decanted
into a clean vial. A second 9-ml portion of hot water was added to the
filters, the vials were incubated at 90°C for 15 min, and this
extract was combined with the first. Approximately 4% of the
total 14C added remained on the filters after the two hot
water extractions. The pooled, hot water extracts from eight assays
were acidified with 5 N H2SO4 to pH 2 and
extracted twice with an equal volume of ethyl acetate. The organic
phase was collected and evaporated to ca. 200 µl with a stream
of nitrogen, and the final volume was measured. Aliquots from the
aqueous and organic fractions were analyzed by liquid scintillation
counting.
Thin-layer chromatography was used to quantify amounts of 2-[14C]CBa and 2-[14C]HBa extracted from the cells. Aliquots (10 µl) of extract were spotted onto a silica gel plate (type 60A; Whatman International Ltd.) along with 50 nmol of unlabeled catechol, 2-CBa, or 2-HBa as a standard, which was included to visualize spot migration. Plates were developed with a hexane-ethyl acetate-acetic acid (90:5:5 [vol/vol/vol]) solvent system. The 2-CBa, 2-HBa and catechol spots were visualized under UV light, excised from the plate, and placed in a scintillation vial for measurement of radioactivity.
For determination of cell dry weight, four aliquots (3 ml each) of cell suspension were filtered through oven-dried Metricel filters (0.45-µm-pore-size diameter; Pall Gelman Laboratory, Ann Arbor, Mich.) and rinsed with 5 ml of double-distilled water. The filters were dried at 105°C for 2 days and cooled in a desiccator, and cell dry weight was calculated from the difference between the final and initial weights (0.83 ± 0.13 mg). Intracellular volume was estimated by assuming 1.5 µl of fluid volume mg-1 of cell dry weight (25, 27, 38), giving a total intracellular fluid volume of cells used in the assay of 1.25 ± 0.19 µl.
Competitor analyses and
metabolic inhibitor tests.
Selected substituted benzoates were
examined as potential competitors of 2-CBa uptake. Test competitors
were added to a final concentration of 10 µM at the initiation
of the uptake assay. For metabolic inhibitor tests, cells were treated
with EDTA to increase their permeability to inhibitors
(19). To do so, cells
were washed once with 100 mM Tris (pH 7.0) and then resuspended in this
buffer. After gentle shaking for 2 min at 30°C, EDTA was added
to a 1 mM concentration and the cells were incubated for an additional
5 min at 30°C. Cells were diluted with 40 ml of inhibitor assay
buffer (described below) and centrifuged immediately at 6,000 x
g for 10 min. Treatment with EDTA had no significant effect
(P < 0.01) on 2-CBa uptake rates. Inhibitors tested
were arsenate, vanadate,
N,N'-dicyclohexylcarbodiimide (DCCD) (Sigma),
KCN, 2,4-dinitrophenol (Sigma), valinomycin (Sigma), nigericin (Sigma),
and carbonyl cyanide m-chlorophenylhydrazone (CCCP; Sigma).
The phosphate analogs (potential inhibitors of ATPase) arsenate and
vanadate required a phosphate-free assay mixture, and so solutions were
buffered with 10 mM 2-(4-morpholino)-ethane sulfonic acid (pH 7.0). For
consistency, all other inhibitors were also tested using
2-(4-morpholino)-ethane sulfonic acid buffer, except for tests with
valinomycin and nigericin. These compounds require
K+ for activity and were examined in the standard
assay buffer. Solutions of DCCD, CCCP, valinomycin, and nigericin were
prepared in ethanol; addition of 10 µl of ethanol alone to the
assay mixture had no significant effect (P < 0.01) on
uptake rates.
Extraction of ATP from cell suspensions was done by
using the perchloric acid method
(19). Ice-cold 24%
(vol/vol) perchloric acid (250 µl) was added to 500 µl
of cell suspension, which contained the same density of cells used in
the transport assay. The mixtures were incubated on ice for 20 min and
centrifuged (16,000 x g, 2 min), and the supernatants
(500 µl) were neutralized with 125 µl of 4 M KOH and
125 µl of 2 M KHCO3. The mixture was incubated on
ice for 30 min and centrifuged as described above. Supernatants were
stored at -20°C for
48 h until
analyzed for ATP. To quantify ATP, 100 µl of Enliten
luciferase-luciferin reagent (Promega, Madison, Wis.) was added to 50
µl of extract and 100 µl of 10 mM Tris (pH 8.0).
Resultant light emissions were quantified with a Monolight 2010
luminometer (Analytical Luminescence Laboratory, San Diego, Calif.),
and relative light units were converted to ATP concentration by
reference to an ATP standard
curve.
Artificially induced
electrochemical gradients.
The methods used to dissipate
electrochemical gradient (
p) and to artificially induce this
or its components (
pH or 
, for electrical
potential gradient) were based on those described by
Groenewegen et al. (10).
Continuous-culture cells were washed once in assay buffer and then
resuspended in K-acetate infusion solution (50 mM
K2PO4 [pH 7.0], 100 mM K-acetate).
Valinomycin was added to a 5 µM concentration, and cells were
incubated for 1 h at 4°C to allow infusion of
K+ and acetate into the cells and thereby dissipate
p. The cells were washed once with, and resuspended in, the
infusion solution. Next, 20 µl of the cell suspension was added
to 1 ml of either of the following: (i) infusion solution (control, no
p), (ii) 50 mM Na2PO4 (pH
7.0)-100 mM Na-HEPES (cytoplasm becomes negatively charged and
alkaline, reestablishes
p), (iii) 50 mM
K2PO4 (pH 7.0)-100 mM K-HEPES (cytoplasm
becomes alkaline, reestablishes
pH), (iv) 50 mM
Na2PO4 (pH 7.0)-100 mM Na acetate
(cytoplasm becomes negatively charged, reestablishes

). Gradient inducement was applied to cells incubated
under aerobic and anaerobic conditions. For the latter, aliquots of the
four solutions described above were boiled, sealed immediately in 20-ml
serum vials, and cooled. These solutions were then flushed with
oxygen-free nitrogen gas for 15 min. The solutions and cells were
anaerobically transferred with gas-tight syringes to a sealed reaction
vial and then flushed with nitrogen for 10 min. Uptake assays were done
as described above with aliquots that were drawn from the mixtures with
a gas-tight syringe.
|
|
|---|
![]() View larger version (15K): [in a new window] |
FIG. 1. Uptake
of 2-CBa and 2-HBa by live and heat-killed cells of P.
huttiensis strain D1. Cells used in the experiment were harvested
from a continuous culture growing on 2-CBa. Each data point is the mean
value from three replicate assays, and error bars indicate the standard
deviation of the
means.
|
Uptake of 2-CBa was enhanced by growth on 2-CBa or 2-HBa, indicating that the system driving uptake (catabolic enzymes or transporter) was inducible. These tests were done with cells from batch cultures, which, when grown on 2-CBa, accumulated 2-[14C]CBa at 1.56 ± 0.11 nmol min-1 mg of protein-1. In batch culture, there was no significant effect of growth phase on 2-CBa uptake rates (data not shown). There was, however, significant variability between batches in transporter activity. We also found that 2-CBa uptake rates of batch-culture-grown cells were always less than those of cells from continuous culture. Differences between batch- and continuous-culture cells in 2,5-DiCBa degradation kinetics were observed by van der Woude and colleagues (36); the physiological basis for the differences observed in the present study and that reported by those investigators remains unknown. Uptake rates of 2-CBa induced by growth on 2-HBa (1.36 ± 0.10 nmol min-1 mg of protein-1) were not significantly different (P < 0.01) from those induced in 2-CBa-grown cells. In contrast, rates of 2-CBa uptake were significantly lower (P < 0.01) for cells grown on glycerol (uptake rate in nmol min-1 mg of protein-1, 0.50 ± 0.11), 2,5-diCBa (0.46 ± 0.13), and benzoate (0.58 ± 0.24). Low levels of uptake in cells grown on these substrates could have reflected diffusion and/or basal-level transporter expression and activity. They were likely not attributable to induction and de novo transporter synthesis during the assay, since adding 50 µg of chloramphenicol ml-1 to the assay mixture did not affect 2-[14C]CBa uptake rates (data not shown). The lack of transporter induction by 2,5-diCBa was noteworthy, since catabolism by strain D1 of 2,5-diCBa and 2-CBa was presumably initiated by the same o-halobenzoate-1,2-dioxygenase (14). This finding, along with those from competitor screening tests reported below, indicated that the substrate spectrum of the transporter mediating 2-CBa uptake differed from that of the dioxygenase-initiating metabolism of this compound.
Analysis of
intracellular/extracellular concentration gradients.
For the 2-CBa experiment, a total of
105 nCi (36 nmol of 2-CBa; extracellular concentration, 4.6 µM)
was captured in the filtrate, and 60 nCi of 14C-labeled
compound was extracted from the cells by hot water. The overall
recovery of radioactivity was 71.1%; mineralization presumably
accounted for the majority of the balance. Most of the 14C
activity in the hot water extracts (72.5% ± 1.1%)
remained in the aqueous phase after acidification and extraction with
ethyl acetate. The amount of 2-CBa in the ethyl acetate extract
(representing the intracellular pool) was 0.62 ± 0.29 nmol
(3.0% ± 1.1% of the hot water-extracted
14C), giving a calculated intracellular concentration of
2-CBa of 500 µM. The intracellular pool of catechol, the first
product of 2-CBa catabolism, was 0.18 ± 0.02 nmol (0.9%
of the hot water-extracted 14C). The majority of the
14C activity in the ethyl acetate (ca. 10% of the hot
water-extracted 14C) remained at the spot origin and was not
identified.
In the 2-HBa experiment, 150 nCi (50 nmol of 2-HBa; extracellular concentration, 6.2 µM) was captured in the filtrate, and 50 nCi of 14C activity was extracted from cells by hot water (overall recovery, 83.3%). Partitioning of 14C in the hot water extract was similar to that observed in the 2-CBa experiment, with most of the radioactivity (66.7% ± 0.2%) remaining in the aqueous phase after ethyl acetate extraction. The amounts of 2-HBa and catechol extracted from the cells were 0.33 ± 0.07 nmol (1.9% of the hot water-extracted 14C) and 0.12 ± 0.03 nmol (1.7% of the hot water-extracted 14C), respectively. The intracellular concentration of 2-HBa was 260 µM.
The intracellular/extracellular concentration ratio) for 2-CBa was 109, while that for 2-HBa was 42, indicating that both substrates were actively accumulated against their concentration gradients. Uptake was thus not driven by metabolic drag but was instead mediated by a transport system. In other bacteria, intracellular accumulations of aromatic acid growth substrates have been previously reported, with the intracellular/extracellular concentration ratio ranging from 8 to 134 (27, 35, 38). In the present study, determinations of the intracellular pools were made on cells continuously growing on 2-CBa at ca. 54% of their maximum rate, and the activity of haloaromatic acid degraders may vary as a function of growth rate as well as other environmental parameters, such as the dissolved oxygen levels (21-23, 34, 36). A next step in this research would be to determine for strain D1 how transporter and catabolic enzyme activity vary as a function of these parameters and the consequent effect on intracellular substrate pools.
Competitors of 2-CBa
uptake.
A significant
reduction (P < 0.01) of
2-[14C]CBa uptake rates was noted with the
additions of several ortho- and meta-substituted
benzoates (Table
1). Uptake was reduced most dramatically by 3-chlorobenzoate (3-CBa) and
2-fluorobenzoate (2-FBa). In the halogen series, the relative level of
inhibition increased with increasing electronegativity of the
substituent. 2-Methylbenzoate, 2-hydoxybenzoate, and 3-bromobenzoate
also significantly decreased 2-CBa uptake rates, but to a lesser extent
than did the other compounds. 2-Nitrobenzoate, benzoate,
2-iodobenzoate, para-substituted benzoates, and di- and
tri-CBa had no significant effect (P < 0.01) on 2-CBa
uptake rates.
|
View this table: [in a new window] |
TABLE 1. Examination
of benzoates as competitors of 2-CBa uptake by 2-CBa-grown cells of
strain D1
|
The patterns of substrate recognition by the carrier provided additional proof that uptake of 2-CBa was mediated by a transporter and was not driven by metabolic drag, and they gave insight into the possible mechanisms of carrier-substrate interaction and the substrate range of the carrier. The data were inconsistent with metabolic drag in that the strongest apparent competitor for uptake (3-CBa) was a relatively poor substrate for the o-halobenzoate-1,2-dioxygenase initiating 2-CBa metabolism (14), and conversely, 2,5-diCBa, which is a good substrate for the dioxygenase (14), was not a competitor for uptake. Nonrecognition of 2,5-diCBa, 2,3-diCBa, 2,3,5-triCBa, benzoate, and para-substituted benzoates may have indicated that a single ortho- or meta-substituent was required for substrate binding. The exclusion of these di- and tri-CBas as substrates for the 2-CBa transporter was notable in that metabolism by strain D1 of all of these growth substrates was presumably initiated by the same o-halobenzoate-1,2-dioxygenase (14). Thus, metabolism of these compounds may involve a different transporter or perhaps may be driven by metabolic drag.
Transporter
energetics: Artificially imposed electrochemical gradients.
Uptake of 2-CBa was abolished by
anaerobic incubation but was rapidly reestablished following exposure
to air (Fig.
2A). Amounts of ATP extracted from cells incubated aerobically and
anaerobically were 6.11 ± 0.08 and 0.46 ± 0.10 nmol mg
of cell protein-1, respectively. Cells treated with
valinomycin and K-acetate to dissipate 
and
pH had no detectable 2-CBa uptake when incubated under aerobic
or anaerobic conditions (Fig.
2B). For cells diluted in
buffers to restore both 
and
pH, or
pH alone, uptake of 2-CBa occurred under aerobic but not
anaerobic conditions (Figs. 2B and
C). In contrast, treatment to restore 
alone did not reestablish 2-CBa uptake by cells incubated aerobically
or anaerobically (Fig.
2C). We attempted to
measure the ATP content of cells treated to impose or
dissipate gradients, but the luminometer readings were
unreliable, apparently because of interference from components of the
solutions used.
![]() View larger version (15K): [in a new window] |
FIG. 2. Effect
of anaerobic conditions and artificially induced electrochemical
gradients on 2-CBa uptake. (A) Cells incubated under
anaerobic conditions; the arrow indicates the point at which some
selected vials were opened to air. (B) Cells with p
dissipated or reestablished, incubated under aerobic or
anaerobic conditions. (C) Dissipation or reestablishment of
pH or ![]() in cells incubated under aerobic or
anaerobic conditions. Each data point in all figures is the mean value
of three replicate assays, and error bars indicate the standard
deviation of the means (obscured by symbols in some cases). Cells used
in the experiment were harvested from a continuous culture growing on
2-CBa.
|
p alone. If the latter were the case, we
would have expected 2-CBa uptake by cells incubated anaerobically with
p restored but uncoupled from ATP formation. An artificial
p was sufficient to support uptake of 4-chlorobenzoate by the
coryneform NTB-1 (10),
4-toluene sulfonate by Comamonas testosteroni T-2
(25), 4-HBa by K.
pneumoniae MAO4 (5),
and 4-HBa by K. planticola DSZ1
(3). Linkage of 2-CBa
uptake to ATP hydrolysis was also indicated by the restoration of
activity under aerobic conditions following treatment to reestablish
pH but not treatment to reestablish 
.
Allende et al. (2)
reported that aerobic incubation and
pH supported 4-HBa uptake
by Acinetobacter sp. strain BEM2; the dependence of uptake on
ATP hydrolysis was further indicated by its elimination following
exposure to DCCD.
Transporter energetics:
metabolic inhibitors.
The
addition of the phosphate analogs vanadate and arsenate had no effect
on rates of 2-CBa transport or ATP levels when tested at 1 and 20 mM,
respectively (Table
2). However, 50 and 100 mM arsenate significantly decreased (P
< 0.01) both uptake and ATP levels. Strain D1 appeared to be
more resistant to arsenate than were bacteria examined in other
transporter studies where lower concentrations of arsenate effected
greater reductions in cellular ATP pools
(2,
3,
5,
25). Treatment with 0.5
mM DCCD had no significant effect (P < 0.01) on either
uptake rates or cellular ATP pools (Table
2). This compound binds to
the F1/Fo ATP synthase (ATPase) complex,
preventing ATP synthesis, and the level tested here greatly exceeded
that reported to affect ATP synthesis for other bacteria. For example,
5 µM DCCD decreased ATP levels by 92% for
Acinetobacter sp.
(5), while less than 100
µM DCCD significantly decreased ATP levels for
Klebsiella (3,
5), Comamonas
(25), Rhizobium
(6), and
Sphingomonas
(38). For strain D1,
exposure to KCN, which interrupts electron transfer, nearly eliminated
2-CBa uptake and almost exhausted cellular ATP pools. The protonophores
CCCP and 2,4-dinitrophenol, which dissipate 
and
pH, significantly decreased (P < 0.01) uptake
rates and ATP levels. Valinomycin, which collapses 
by rendering cells permeable to K+, had no
significant effect (P < 0.01) on either transport or
ATP levels. The ionophore nigericin, which dissipates
pH by
facilitating the exchange of H+ for
K+, also did not significantly decrease either
uptake rates or ATP levels (Table
2).
|
View this table: [in a new window] |
TABLE 2. Effect
of metabolic inhibitors on 2-CBa uptake rates and cellular ATP levels
measured with 2-CBa-grown cells of strain D1
|
p, which inhibits secondary transporters, is
confounded by the accompanying depletion of ATP, which inhibits primary
transporters (18,
19,
30,
37).
Role
of hybEFG in transport of 2-CBa or 2-HBa.
Mutagenesis experiments were done to
determine if hybEFG encoded the transporter that mediated
uptake of 2-HBa and 2-CBa. The vector used, pBSL202, contained a
mini-Tn5 to effect random insertional mutagenesis
(1) and was maintained in
E. coli S17-1
pir. The vector was introduced
into strain D1 by electroporation, and a number of
gentamicin-resistant, putative strain D1 mutants were recovered.
However, hybridization and plasmid screening showed that none of these
had transposon inserts, but instead they had retained pBSL202 as a
stably replicating plasmid. This was surprising, since replication of
the vector is dependent on expression of the pir gene, which
is supplied in trans in E. coli and presumably is
absent in the recipient
(1).
Although the procedure did not generate the intended insertional mutants, PCR screening of the transformants identified one from which hybEFGH failed to amplify. In Southern hybridization analysis of this transformant, a probe to hybE detected a 7.9-kb EcoRI fragment, as expected, but not a second expected 2.9-kb fragment (Fig. 3). In SacI digests of the transformant, the hybE probe hybridized to a 5-kb fragment, which was 3.7 kb smaller than expected (Fig. 3). Probing AvaII digests with hybE yielded the expected 2.7-kb fragment (Fig. 3). Hybridization of an ORFA probe to AvaII-digested DNA gave the expected fragments, including the 1.4-kb fragment that was bounded by map positions 24.8 and 23.4 kb (Fig. 3). Collectively, the hybridization patterns of hybE in the EcoRI, SacI, and AvaII digests suggested that hybE (and the upstream hyb region) was intact but that a ca. 3.7-kb deletion occurred downstream of hybE. The exact points of deletion were not determined, but we could conclude that it occurred within the 4-kb region bounded downstream by map position 23.4 kb and upstream by map position 19.4 (Fig. 3). This deletion effectively eliminated hybF and hybG, the putative products of which had significant identity to ATP-binding proteins of an ABC-type transporter.
![]() View larger version (13K): [in a new window] |
FIG. 3. Physical
map of the hybEFG genes and adjoining regions. Locations of
restriction sites for the enzymes listed are indicated by the vertical
bars and are numbered (in kilobases) relative to distance from the
beginning of the 26-kb region in which they were originally identified
(15). For EcoRI,
a restriction site located at 10.5 kb that is off the map at the scale
used is indicated by the gap. The dashed line indicates the 4-kb region
in which the 3.7-kb deletion occurred in the hybFG mutant.
Solid lines indicate probes used in Southern hybridization analysis of
the
mutant.
|
The activity of ABC transporters is dependent on the hydrolysis of ATP, which is mediated by specific ATP-binding proteins with which they associate (16). Thus, the loss of the hybF and hybG would be expected to render the putative transporter encoded by hybEFG nonfunctional. Since 2-CBa or 2-HBa uptake by a deletion mutant was no different from that of the wild type, it was unlikely that a hybEFG-encoded transporter mediated this process. However, the fact that strain D showed no uptake of 2-CBa suggests that genes encoding the transporter were carried on the same mobile element as the hyb and ohb genes.
Conclusions.
Uptake of 2-CBa and 2-HBa is mediated
by an inducible transporter in strain D1. The relative rates of
activity for the transporter were comparable with those reported for
other aromatic acids. The substrate range of the transporter did not
include other o-halobenzoates that serve as growth substrates
for strain D1 and for which the metabolism is initiated by the same
dioxygenase as for 2-CBa and 2-HBa. This suggests that multiple
mechanisms for substrate uptake were coupled to the same catabolic
enzyme. Substrate binding and/or translocation appeared to be favored
by a single, electronegative substituent in the ortho or
meta position. The preponderance of evidence suggested that
2-CBa uptake was driven by ATP hydrolysis. If so, the 2-CBa transporter
would be the first of the ABC type implicated in uptake of haloaromatic
acids.
These studies were funded by U.S. EPA grant R82-7103-01-0 to W.J.H. and Hatch project W1504466 to W.J.H.
Present
address: Department of Pathobiological Sciences, University of
WisconsinMadison, Madison, WI 53706-1299. ![]()
Present
address: Biotechnology Center, University of WisconsinMadison,
Madison, WI 53706-1299. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»